Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Public ClinicalTrials.gov record NCT02393417. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a placebo-controlled, double-blind (subject, Investigator, and site staff with the exception of unblinded dedicated staff to handle study medication), phase 2a study with 3 dose cohorts, randomized (concealed) to CANDIN or placebo (3:1). Main study will be up to 20 weeks (10 doses administered every other week) or until a subject has complete resolution of all injectable common warts. Subjects who cannot tolerate dosing every 2 weeks due to a local tolerance issue may be injected at 3-week intervals for up to 10 doses, increasing the length of the study to 29 weeks. Subjects will be followed for 4 months after final injection(s) for evidence of new or reoccurring warts and for safety evaluation.
Study identification
- NCT ID
- NCT02393417
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 243 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2015 (Actual)
- Primary completion
- Jan 2018 (Actual)
- Completion
- Mar 2018 (Actual)
- Last update posted
- Jun 4, 2019
2015 – 2018
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| Northwest Arkansas Clinical Trials Center PLLC | Rogers | Arkansas | 72758 | — |
| California Dermatology and Clinical Research Institute | Encinitas | California | 92024 | — |
| Silverberg MD Inc. | Newport Beach | California | 92660 | — |
| Metro Boston Clinical Partners, LLC | Needham | Massachusetts | 02492 | — |
| BayState Clinical Trials | Watertown | Massachusetts | 02472 | — |
| Hamzavi Dermatology Clinical Trials | Fort Gratiot | Michigan | 48059 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Austin Institute for Clinical Research Inc. | Austin | Texas | 78660 | — |
| DermResearch Inc. | Austin | Texas | 78759 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Dermatology Research Center, Inc. | Salt Lake City | Utah | 84117 | — |
| The Education and Research Foundation, Inc. | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02393417, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2019 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02393417 live on ClinicalTrials.gov.